» Articles » PMID: 22696035

Diabetic Nephropathy in Type 1 Diabetes: Has the Outlook Improved Since the 1980s?

Overview
Journal Diabetologia
Specialty Endocrinology
Date 2012 Jun 15
PMID 22696035
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

This edition of Then and Now discusses three papers published in Diabetologia in the 1980s relating to diabetic nephropathy. Two epidemiological papers by Andersen et al (1983; 25:496-501) and Borch-Johnsen et al (1985; 28:590-596) described in graphic detail the ravages of diabetic nephropathy in type 1 diabetes. After 40 years of diabetes, 41% of their cohort had developed persistent proteinuria. The median time from first appearance of proteinuria to death was 7-8 years, the majority dying of uraemia or cardiovascular disease. The third paper, by Mathiesen et al (1984; 26:406-410), identified individuals with microalbuminuria, a much earlier stage of diabetic nephropathy, and analysed the risk of progression to persistent proteinuria at various levels of urine albumin excretion. Since the description of microalbuminuria, clinicians have hoped that earlier identification of individuals at high risk of end-stage kidney disease, coupled with aggressive use of reno-protective therapies, would prevent, or at the very least significantly delay, the development of end-stage renal disease. Recent data suggest that the outlook has indeed improved since the 1980s, at least in some populations. However, we may be delaying rather than preventing the development of microalbuminuria, proteinuria and kidney failure. Whilst a delay of 10 or more years in the appearance of end-stage renal disease is very welcome, further work is needed to understand why rates of chronic kidney disease vary substantially between cohorts and to develop novel therapies.

Citing Articles

Emerging role of neutrophil extracellular traps in the complications of diabetes mellitus.

Shafqat A, Abdul Rab S, Ammar O, Al Salameh S, Alkhudairi A, Kashir J Front Med (Lausanne). 2022; 9:995993.

PMID: 36082273 PMC: 9445264. DOI: 10.3389/fmed.2022.995993.


miR-188-3p abolishes germacrone-mediated podocyte protection in a mouse model of diabetic nephropathy in type I diabetes through triggering mitochondrial injury.

Wang Y, Feng F, He W, Sun L, He Q, Jin J Bioengineered. 2021; 13(1):774-788.

PMID: 34847832 PMC: 8805940. DOI: 10.1080/21655979.2021.2012919.


Early functional and metabolic disorders in children with type I diabetes mellitus and diabetic nephropathy.

Burlaka I, Maidannyk V Pediatr Endocrinol Diabetes Metab. 2021; 27(3):170-177.

PMID: 34743502 PMC: 10228199. DOI: 10.5114/pedm.2021.107720.


A review of risk factors associated with insulin omission for weight loss in type 1 diabetes.

Hall R, Keeble L, Sunram-Lea S, To M Clin Child Psychol Psychiatry. 2021; 26(3):606-616.

PMID: 34121470 PMC: 8264633. DOI: 10.1177/13591045211026142.


Early Detection of Diabetic Peripheral Neuropathy: A Focus on Small Nerve Fibres.

Burgess J, Frank B, Marshall A, Khalil R, Ponirakis G, Petropoulos I Diagnostics (Basel). 2021; 11(2).

PMID: 33498918 PMC: 7911433. DOI: 10.3390/diagnostics11020165.


References
1.
Mollsten A, Svensson M, Waernbaum I, Berhan Y, Schon S, Nystrom L . Cumulative risk, age at onset, and sex-specific differences for developing end-stage renal disease in young patients with type 1 diabetes: a nationwide population-based cohort study. Diabetes. 2010; 59(7):1803-8. PMC: 2889782. DOI: 10.2337/db09-1744. View

2.
Nordwall M, Bojestig M, Arnqvist H, Ludvigsson J . Declining incidence of severe retinopathy and persisting decrease of nephropathy in an unselected population of Type 1 diabetes-the Linköping Diabetes Complications Study. Diabetologia. 2004; 47(7):1266-1272. DOI: 10.1007/s00125-004-1431-6. View

3.
Hovind P, Tarnow L, Rossing K, Rossing P, Eising S, Larsen N . Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes. Diabetes Care. 2003; 26(4):1258-64. DOI: 10.2337/diacare.26.4.1258. View

4.
Mathiesen E, Oxenboll B, Johansen K, Svendsen P, Deckert T . Incipient nephropathy in type 1 (insulin-dependent) diabetes. Diabetologia. 1984; 26(6):406-10. DOI: 10.1007/BF00262210. View

5.
de Boer I, Rue T, Cleary P, Lachin J, Molitch M, Steffes M . Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort. Arch Intern Med. 2011; 171(5):412-20. PMC: 3085024. DOI: 10.1001/archinternmed.2011.16. View